representative of the company during the FDA stud- ies. The paper was reviewed by the sponsor; how- ever, the sponsor did not exert editorial influence. All of the data presented was available to the author
of these abstracts and all of the data is/will be pub- licly available through the FOI. The FDA does exert influence by limiting statements to those proven by the data.